2019 International Congress Archives - Page 130 of 217

A case of Aceruloplasminemia with vertical saccadic eye movement abnormalities

O. Dogu, N. öksüz, H. Kaleagasi (Mersin, Turkey)
A case of cerebellar ataxia caused by Pembrolizumab for Non-small cell lung cancer

T. Moto, H. Nagayama, K. Kimura (Tokyo, Japan)
A Case of Diurnally Variable Gut Discomfort in a Patient with RLS

J. Coleman, A. Amara (Birmingham, AL, USA)
A case of donepezil-induced multifocal myoclonus

C. Amlang, P. Kim, A. Padalia, B. Roy, S. Schaefer (New Haven, CT, USA)
A case of dystonia with dystonic tremor treated with DBS targeting the VOA and VIM thalamus

L. Jackson, B. Klassen, J. Bower, F. Ali (Rochester, MN, USA)
A case of hemimasticatory spasm with well therapeutic response to serial injections of botulinum toxin

SK. Yang, JJ. Lin (Changhua County, Taiwan)
A case of osmotic demyelination syndrome presenting parkinsonism affected by blood alcohol concentration change

M. Kondo, A. Unaki, T. Kimura (Tokyo, Japan)
A Case of Pregabalin induced Parkinsonism

BC. Ari, F. Mayda Domac, G. Ozgen Kenangil (Istanbul, Turkey)
A Case of Secondary Myoclonic Hyperkinesia

H. Amirjanyan, K. Harutyunyan (Nor Hach, Armenia)
A case of severe blepharospasm after psoralen and ultraviolet A treatment

P. Ferreira, S. Moreira (Senhora da Hora, Portugal)
A Case Presentation of Wilson’s Disease

D. Al Elwany, S. Ahmed, H. Deraz, C. Ragaey (Cairo, Egypt)
A case report of two siblings Aicardi-Goutières Syndrome type 2

C. Fujiwara Murakami, E. Nakagawa, A. Meira, F. Germiniani, E. Pereira, H. Ghizoni Teive (Curitiba, Brazil)
A case report of Wilson Disease in a Kyrgyz teenager

A. Jusupova (Bishkek, Kyrgyzstan)
A characterization of the ADL-level in daily life with Parkinson`s Disease based on objective measurements and subjective experiences.

T. Thomsen, T. Kjær, L. Jørgensen, A. Haahr, K. Winge (Roskilde, Denmark)
A coding VPS13C haplotype is associated with reduced risk for Parkinson disease

U. Rudakou, J. Ruskey, L. Krohn, S. Laurent, D. Spiegelman, L. Greenbaum, G. Yahalom, A. Desautels, J. Montplaisir, S. Fahn, C. Waters, L. Levy, C. Kehoe, S. Narayan, Y. Dauvilliers, N. Dupré, S. Hassin-Baer, R. Alcalay, G. Rouleau, E. Fon, Z. Gan-Or (Montreal, QC, Canada)
A Comparative Study of Measured and Predicted Metrics of Respiratory Function in People with Parkinson’s Disease (PD)

L. Mcmahon, O. Lennon, C. Blake, D. Mcgrath (Dublin, Ireland)
A comparison of serial position effects between patients with MCI due to Parkinson’s disease and patients with MCI due to Alzheimer’s disease

A. Meyer, I. Handabaka, MM. Ehrensperger, U. Gschwandtner, F. Hatz, AU. Monsch, RD. Stieglitz, P. Fuhr (Basel, Switzerland)
A cortical signature of motor response to dopaminergic therapy in Parkinson’s disease

J. Baarbé, K. Lizarraga, J. Saravanamuttu, U. Saha, R. Chen (Toronto, ON, Canada)
A descriptive study with molecular and cytogenetic analysis in patients of ataxia telangiectasia(AT) from the Indian subcontinent

S. Das, S. Danda, M. Thomas, S. Yoganathan, V. Srivastava, S. Cleave A, A. Barney (Vellore, India)
A detailed delineation of the clinical phenotype, natural history and quality of life in patients with North Sea Progressive Myoclonus Epilepsy

S. Polet, L. Koens, M. van Egmond, D. Sival, E. Brusse, M. Willemsen, R. Lambrechts, O. Brouwer, G. Drost, H. Kremer, J. de Vries, M. de Koning-Tijssen, T. de Koning (Groningen, Netherlands)
A Dual-Center Study of Pain and Other Non-motor Symptoms in Parkinson disease

P. Ghosh, P. Imbriani, N. Caputi, L. Covington, A. Sparks, T. Schirinzi, Y. Salnikova, S. Natoli, A. Pisani (Washington Dc, DC, USA)
A family of Phospholipase A2-associated neurodegeneration presented as complicated hereditary spastic paraplegia

MC. Wu, MY. Lan, JW. Li, YF. Chen, YY. Chang (Kaohsiung, Taiwan)
A First in Human Study of PBT434, a Novel Small Molecule Inhibitor of Alpha-Synuclein Aggregation

D. Stamler, M. Bradbury, C. Wong, E. Offman (Newark, CA, USA)
A flowchart algorithm for the neurologist to discuss and attend sexual issues in Parkinson’s disease

G. Bronner, S. Hassin-Baer, AD. Korczyn, T. Gurevich (Ramat-Gan, Israel)
A general impaired-rhythm system underpins oro-motor, manual, and gait rhythmic disturbances in Parkinson’s disease

F. Puyjarinet, V. Bégel, C. Gény, V. de Cock, V. Driss, M. Cuartero, S. Pinto, S. Dalla Bella (Montpellier, France)
A genome wide pleiotropic approach to identify the genetic architecture of multiple system atrophy and its interaction with Parkinson’s disease

A. Ashokkumar Sreelatha, A. Shadrin, C. Blauwendraat, O. Frei, T. Gasser, G. Wenning, A. Singleton, H. Houlden, S. Scholz, O. Andreassen, M. Sharma (Tübingen, Germany)
A genome-wide genetic pleiotropy approach identified shared loci between multiple system atrophy and inflammatory bowel/Crohn’s disease

A. Shadrin, A. Sreelatha, S. Mucha, C. Blauwendraat, O. Frei, D. Ellinghaus, A. Franke, G. Wenning, A. Singleton, T. Gasser, H. Houlden, S. Scholz, O. Andreassen, M. Sharma (Oslo, Norway)
A global survey on speech language therapists’ awareness to Huntington’s disease

A. Nuzzi, S. Naor, N. Inbar, T. Gurevich, Y. Manor (Santeramo In Colle, Italy)
A hexanucleotide repeat within a SINE-VNTR-Alu retrotransposon inserted in TAF1 modifies expressivity of X-linked dystonia-parkinsonism

A. Westenberger, C. Reyes, G. Saranza, V. Dobricic, H. Hanssen, A. Domingo, B-H. Laabs, A. Rakovic, P. Bauer, A. Rolfs, A. Münchau, L. Ozelius, R.. Jamora, R. Rosales, C. Diesta, K. Lohmann, I. König, N. Brüggemann, C. Klein (Kalakhang Maynila, Philippines)
A homozygous pentanucleotide repeat expansion in cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS)

M. Gisatulin, V. Dobricic, Y. Hellenbroich, V. Tadic, A. Münchau, C. Zühlke, M. Bahlo, P. Lockhart, K. Lohmann, C. Helmchen, N. Brüggemann (Lübeck, Germany)
A hot, cold case of Parkinson’s disease: Charcot and Bachère: was this case misdiagnosed?

R. Kikuchi, T. Okamoto, S. Akaike, M. Miller, M. Kawamura (Tsurumi-Ku, Yokohama, Kanagawa, Japan)
A Human Factors Study of the DopaFuse® Delivery System

J. Harmon, S. Japp, C. Long, J. Spiridigliozzi, A. Heller, B. Heller, C. King, P. Plante, R. Draper, T. Lau, E. Heller (Bala Cynwyd, PA, USA)
A Korean case of Fragile X-associated mild ataxia without tremor

WW. Lee, BK. Kim, O. Kwon, JM. Park, JJ. Lee, K. Kang (Seoul, Republic of Korea)
A Large-Scale Survey of Rock Steady Boxing (RSB) Utilization in Parkinson’s Disease

D. Bega, D. Larson, M. Rafferty (Chicago, IL, USA)
A Lewy body disease of widely confirmed Lewy bodies in the cerebral cortexes including the occipital lobe without pathological changes in the hippocampal CA2/3 region

M. Ryo, K. Hasegawa, I. Saitoh, S. Yagishita (Tokyo, Japan)
A life-threatening case of Anti-IgLON5 disease

M. Filidei, N. Tambasco, F. Paolini Paoletti, S. Simoni, E. Brahimi, G. Cappelletti, P. Nigro, P. Calabresi (Perugia, Italy)
A machine learning approach to predict non-responders to subthalamic nucleus deep brain stimulation in Parkinson disease patients based on preoperative characteristics

J. Habets, M. Janssen, A. Duits, B. de Greef, A. Mulders, L. Sijben, Y. Temel, M. Kuijf, P. Kubben, C. Herff (Maastricht, Netherlands)
A Multiple Ascending-Dose Study of LY3154207, A Dopamine D1 Receptor Positive Allosteric Modulator (D1PAM)

K. Biglan, D. Wilbraham, K. Svensson, M. Tsai, W. Kielbasa (Indianapolis, IN, USA)
A Neuroscientific approach for MCI Characterization using a Motor and Cognitive Dual-Task

G. Mancioppi, F. Fiorini, M. Timpano Sportiello, E. Rovini, F. Cavallo (Pontedera, Italy)
A new screening tool to detect psychoaffective states in patients with Parkinson´s disease

C. Schedlich-Teufer, M. Sommerauer, S. Jost, S. Schnitzler, H. Dafsari, E. Kalbe, J. Kessler, M. Barbe (Cologne, Germany)
A novel heterozygous ANO3 mutation responsible for myoclonus-dystonia

C. Laurencin, E. Broussolle, T. Danaila, M. Anheim, J. Chelly, S. Thobois (Lyon, France)
A novel intermittent control paradigm to investigate oscillatory neuronal activity in the STN

M. Boca, N. Ray, C. Kobylecki, J. Evans, I. Loram, M. Silverdale (Manchester, United Kingdom)
A novel intronic pentanucleotide TTTGA repeat insertion in SAMD12 causes familial cortical myoclonic tremor with epilepsy type 1

ZD. Cen, Y. Chen, S. Chen, XH. Chen, B. Wang, F. Xie, OY. Zhiyuan, ZW. Jiang, AS. Fu, B. Hu, HM. Yin, X. Qiu, F. Yu, XP. Du, WC. Has, YX. Liu, HT. Wang, DH. Yang, LB. Wang, CY. Liu, JF. Xiao, BR. Zhang, W. Luo (Hangzhou, China)
A novel intronic variant in MAPT causes FTLD-parkinsonism: Implications for regulatory mechanism of MAPT pre-mRNA splicing

P. Gonzalez-Latapi, B. Bustos, D. Larson, L. Kinsley, N. Siddique, T. Siddique, T. Simuni, E. Bigio, S. Lubbe, R. de Silva, D. Krainc, N. Mencacci (Chicago, IL, USA)
A novel p.Trp42Arg REEP1 mutation associated with autosomal recessive Distal spinal muscular atrophy with vocal cord and diaphragmatic paralysis

R. Kaiyrzhanov, R. Maroofian, M. Behnam, M. Salehi, V. Salpietro, H. Houlden (London, United Kingdom)
A novel TGM6 heterozygous mutation in a patient with cerebellar ataxia

A. Manini, T. Bocci, E. Monfrini, D. Ronchi, M. Vizziello, G. Franco, A. de Rosa, F. Sartucci, A. Di Fonzo (Milan, Italy)
A Phase 2 Dose Escalation Study of Ampreloxetine (TD-9855), a Norepinephrine Reuptake Inhibitor, Given Once-Daily to Treat Neurogenic Orthostatic Hypotension (nOH) in Subjects with Synucleinopathies

H. Kaufmann, I. Biaggioni, K. Chatamra, A. Panneerselvam, B. Haumann, R. Vickery (New York, NY, USA)
A Phase 2 Study of the Efficacy, Durability and Safety of Ampreloxetine (TD-9855), a Norepinephrine Reuptake Inhibitor, Given Once-daily to Treat Neurogenic Orthostatic Hypotension (nOH) in Subjects with Synucleinopathies

H. Kaufmann, I. Biaggioni, K. Chatamra, A. Panneerselvam, B. Haumann, R. Vickery (New York, NY, USA)
A Phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson’s disease (STEADY-PD III): Final study results

T. Simuni (Chicago, IL, USA)
A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson’s disease dementia

P. Svenningsson, P. Odin, N. Dizdar, F. Bergquist, A. Johansson, D. Nyholm, K. Wictorin, J. Tedroff (Uppsala, Sweden)
A Pilot Study of Gamma Knife Radiosurgery Targeting the Subthalamic Nucleus in Elderly and Infirmed Parkinson’s Disease Patients Not Amenable to Deep Brain Stimulation

P. Drummond, M. Pourfar, D. Kondziolka (New York, NY, USA)
A pilot study of the feasibility and effects of table tennis training in Parkinson’s Disease

K. Olsson, A. Johansson, E. Franzén (Stockholm, Sweden)
A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment

K. Amodeo (Rochester, NY, USA)
A Prospective Study of the Effects of Deep Brain Stimulation on Constipation and Olfaction in Parkinson Disease

S. Kola, A. Bharucha, D. Prichard, K. Feuerhak, A. Hassan (Rochester, MN, USA)
A protocol to probe the mechanisms underlying disordered sub-cortical processing in cervical dystonia using emotional faces.

S. Purcell, J. Monahan, I. Ndukwe, O. Killian, S. Narasimham, M. Perez Denia, O. Duggan, S. O Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)
A Protocol to Test the Effects of TDCS on Consolidation of Writing Practice in Parkinson’s Disease

S. Broeder, T. Kramer, R. Meesen, G. Verheyden, JJ. Orban Dexivry, A. Nieuwboer (Leuven, Belgium)
A randomised rater-blinded study of motor consequences of inactivity in Parkinson’s disease revealing a new phenomenon: Stasis Induced Akinesia

M. Schumacher, S. Tisch (Sydney, Australia)
A randomized clinical trial of multimodal balance training with rhythmical cues: effects on freezing of gait in Parkinson’s disease

T. Capato, N. de Vries, J. Inthout, J. Ramjith, E. Barbosa, J. Nonnekes, B. Bloem (Nijmegen, Netherlands)
A randomized, placebo-controlled, double-blind clinical study in Japan of Opicapone treatment for Parkinson’s Disease -Comfort-PD Study part 1

A. Takeda, R. Takahashi, Y. Tsuboi, M. Nomoto, T. Maeda, A. Nishimura, N. Hattori (Sendai, Japan)
A recessive repeat expansion causes CANVAS and is a common cause of Late-Onset Ataxia

H. Houlden, M. Reilly, S. Zuchner, W. Marques, P. Fratta, A. Bronstein, A. Rossor, A. Rebelo, E. Buglo, N. Andrade, N. Wood, D. Kaski, S. Efthymiou, V. Salpietro, M. Versino, I. Callegari, D. Devigili, P. Tomaselli, E. Tribollet, M. Ilyas, J. Polke, P. Sivakumar, Z. Jaunmuktane, J. Humphrey, Y. Yan, H. Tariq, J. Vandrovcova, R. Sullivan, R. Simone, A. Cortese (London, United Kingdom)
A Registry for Parkinson’s Disease in Utah

P. Moretti, A. Nakashima, M. Zorn, S. Woltz, L. Farese, L. Cannon-Albright, S. Pulst (Salt Lake City, UT, USA)
A retrospective analysis of clinical and electrophysiological characteristics of patients with myoclonus

A. Gunduz, M. E. Kızıltan, H. Ser, N. Yeni, C. Ozkara, V. Demirbilek, C. Yalçınkaya, G. Kızıltan (Istanbul, Turkey)
A review of interactive voice response systems in Parkinson’s Disease

J. Domingues, T. Guerreiro, D. Branco, A. Rodrigues, R. Bouça-Machado, J. Ferreira (Aveiro, Portugal)
A Robust and Rapid Method of PCR amplification To Confirm Triplet Repeat Disorders: Single-Step Blood Direct PCR

I. Singh, V. Swarup, S. Shakya, V. Goyal, A. Srivastava (New Delhi, India)
A safety, tolerability and biomarker update from an ongoing open-label extension study of RG6042 in adults with early manifest Huntington’s disease

S. Tabrizi, B. Leavitt, P. Sanwald Ducray, E. Wild, V. Schlegel, G. Hooper, A. Nicotra, J. Chevure, A. Smith, R. Lane, F. Bennett, L. Boak, R. Doody, S. Schobel (London, United Kingdom)
A single nigral injection of human ENGRAILED-1 induces long-lasting behavior benefit in an experimental primate model of Parkinson Disease

A. Prochiantz, E. Pioli, C. Friedel, K. Moya, E. Bézard, A. Bousseau (Paris, France)
A Smart Device System (Wearable technology band) to Identify New Phenotypical Characteristics in Parkinson‘s disease patients

V. Sharma, S. Sharma (Delhi, India)
A software framework for objective and quantitative audio-analysis of Embouchure Dystonia (ED)

M. Perez Denia, O. Killian, I. Ndukwe, S. Narasimham, S. O’Riordan, M. Hutchinson, R. B. Reilly (Dublin, Ireland)
A study for expanding application sites of rotigotine transdermal patch

S. Itaya, Y. Choh, M. Takahashi, A. Inaba, K. Orimo, Y. Ono, H. Kujirai, S. Orimo (Tokyo, Japan)
A study of factors causing psychiatric abnomalities in patients with Parkinson’s disease

T. Syed, R. Borgohain (Hyderabad, India)
A Study of Microglial Metabolism in Neuroinflammation

T. Domenick, B. Cyr, R. Yost, M. Okun, V. Vedam-Mai (Gainesville, FL, USA)
A study of Mutation in ATP7B gene and its correlation with clinical phenotype and radiological features in patients of Wilson Disease-a population based study in a tertiary care institute in eastern India

J. Chaudhuri, T. Biswas, A. Biswas, S. Biswas, G. Gangopadhyay, A. Dutta (Kolkata, India)
A Study of Social Cognition in Parkinson’s Disease

S. Meenakshisundaram, LN. Ranganathan (Chennai, India)
A Systems Approach Model for Pantothenate Kinase-Associated Neurodegeneration (PKAN)- Assessment and Treatment

S. Baser, C. Muniz, F. Middleton, R. Ericson, C. Bass (Pittsburgh, PA, USA)
A Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson’s Disease Complicated By “OFF” Episodes

F. Stocchi, K. Wilks, E. Peckham, M. de Pandis, K. Sciarappa, F. Agbo, R. Kleiman, D. Blum, B. Navia (Rome, Italy)
A Unified Staging System for Prodromal and Manifest Huntington’s disease

A. Mohan, Z. Sun, S. Ghosh, Y. Li, Y. Cheng, J. Hu, C. Sampaio (Yorktown Heights, NY, USA)
A videographic tool for quantitative assessment of the Glabellar Reflex

A. Braczynski, J. Schulz, S. Leonhardt, C. Hoog Antink (Aachen, Germany)
Aberrant structural connectivity of the executive network in Progressive Supranuclear Palsy

S. Prasad, A. Rajan, S. Mangalore, J. Saini, M. Ingalhalikar, P. Pal (Bangalore, India)
Abnormal frontal theta and beta oscillations during gait observation in Parkinson’s disease

AS. Singh, AIE. Espinoza, NN. Narayanan (Iowa City, IA, USA)
Abnormal Gait in Cerebrotendenious Xanthomatosis a case report

H. Amer, S. Ali, S. Sherif, S. El-Jaafary (Cairo, Egypt)
Abnormal Intracortical Facilitation in patients of Parkinson’s disease with REM Sleep Behavior Disorder

A. Bhattacharya, N. Kamble, R. Yadav, PK Pal
Abnormal metabolic brain network in multiple system atrophy and progressive supranuclear palsy: a replication on a new European cohort

T. Rus, E. Rebec, P. Tomše, A. Studen, M. Grmek, C. Tang, D. Eidelberg, M. Trošt (Ljubljana, Slovenia)
Abnormal posture during treatment of restless legs syndrome in an old woman: A case report

K. Hirata, K. Suzuki, M. Saito, T. Shiina, H. Sakuramoto, M. Hamaguchi, T. Kadowaki (Mibu, Japan)
Abnormal respiratory rate and patterns in MSA

E. Driver-Dunckley, B. Goodman (Scottsdale, AZ, USA)
Abnormal Sensorimotor Processing in Cervical Dystonia in Functional Magnetic Resonance Imaging

L. Hvizdosova, P. Hok, D. Lachmanova, M. Nevrly, P. Otruba, P. Hlustik, P. Kanovsky (Olomouc, Czech Republic)
Abnormal thalamo-cortical functional connectivity patterns in Gilles de la Tourette Syndrome: a seed-based resting state fMRI study

L. Zapparoli, M. Porta, F. Devoto, N. Tedone, D. Servello, E. Paulesu (Milan, Italy)
AbobotulinumtoxinA Using 2 mL Dilution Maintains Durable Functional Improvements Across Multiple Treatment Cycles

K. Dashtipour, J. Otto, P. Maisonobe, L. Bahroo, D. Truong, R. Trosch (Loma Linda, CA, USA)
AbobotulinumtoxinA: evidence for long duration of response

K. Foster, A. Lysandropoulos, P. Picaut (Abingdon, United Kingdom)
Accelerometer-Based Gait Analysis for Patients with Parkinson’s Disease

S-T. Tang, C-H. Tai, Y-H. Lai, T-C. Lee (Taoyuan, Taiwan)
Acceptability and Effectiveness of an Online Curriculum in Movement Disorders for Neurology Housestaff: A pilot study

S. Schaefer, L. Vadlamani, P. Juthani, J. Moeller (New Haven, CT, USA)
Accuracy of clinical diagnosis of atypical parkinsonism: comparison of consensus clinical criteria with MRI criteria

D. Gwendoline, G. David, D. Bertrand, L. Stephane, C. Florence (Paris, France)
Accuracy of preoperative microelectrode trajectory planning in patients treated with DBS – an ongoing study

S. Ibrulj, S. Delalić, MB. Benedičič, D. Georgijev, DF. Flisar, M. Trošt (Ljubljana, Slovenia)
Accuracy of the MoCA in Detecting PD-MCI in the Ontario Neurodegenerative Disease Research Initiative study

KB. Zaidi, C. Marras, A. Troyer, A. Lang, M. Masellis, D. Grimes, D. Kwan, JB. Orange, A. Roberts, B. Levine, M. Jog, T. Steeves, B. Tan, P. Mclaughlin (Toronto, ON, Canada)
Acquired (non-Wilsonian) hepatocerebral degeneration: case report

E. Gracheva, I. Miliukhina, A. Sokolov, YU. Seliverstov (St.petersburg, Russian Federation)
Acquired hepatocerebral degeneration treated with calcium disodium edetate chelation

Z. Voysey, L. Azzopardi, B. Fiddes, S. Bradberry (Romford, United Kingdom)
Actigraphically Characterized Infradian Rest-Activity Rhythms in Parkinson’s Disease

C. Brooks, R. Koehler, MK. Erb, F. Mortazavi, J. Bhangu, K. Thomas (Boston, MA, USA)
Activity of Cerebral Networks, Amyloid and Microglia in Corticobasal Syndrome: the ActiGliA study

C. Palleis, J. Levin, M. Brendel, L. Beyer, BS. Rauchmann, S. Loosli, E. Wlasich, K. Boetzel, A. Danek, R. Perneczky, C. Haass, G. Hoeglinger (Munich, Germany)
Activity of Neurosteroid GABAA Positive Allosteric Modulators in Preclinical Harmaline Model for Essential Tremor

R. Hammond, A. Robichaud, J. Doherty, F. Salituro, M. Quirk, M. Ackley, B. Farley, S. Mctighe, T. Kazboda, A. Althaus, C. Maciag, M. Blanco, S. Gee (Cambridge, MA, USA)
Acupuncture as Adjuvant Therapy for the Management of Cervical Dystonia

D. Bega, K. Park, A. Grimone, F. Lin, M. Ring (Chicago, IL, USA)
Acute chorea secondary to cephalosporin

BED. Ines, BRA. Zeineb, MAN. Malek, ZAO. Jamel, MRI. Ridha (Tunis, Tunisia)
Acute hemichorea caused by infarction over globus pallidus interna

YP. Chang (Kaohsiung, Taiwan)
Acute hemichorea in patient of uncontrolled type 2 diabetes mellitus; a case report with characteristic imaging

M. Salem, A. Helmy, E. Abdeldayem, A. Shalash (Cairo, Egypt)
Acute hypertensive crisis with myoclonic movements induced by withdrawal of intrathecal combined clonidine and morphine administration

A. Saryyeva, J. Krauss, L. Cassini Ascencao (Hannover, Germany)
Acute Onset Parkinsonism Secondary to West Nile Virus Encephalitis

M. Purbaugh, F. Ali, T. Diesing, A. Hellman (Omaha, NE, USA)
Acute parkinsonism following an obstructive hydrocephalus and a ventriculoperitoneal shunt revision: a case report

J. Majuri, HR. Maanpää, A. Kotkansalo, J. Korpela, J. Joutsa (Lahti, Finland)
Acute unilateral involuntary movement in a patient with posterior reversible encephalopathy syndrome

P-Y. Chen (Taipei, Taiwan)
Acute, contact-dependent behavioral changes in Parkinson disease (PD) patients during monopolar contact review of subthalamic deep brain stimulation (DBS) using directional leads

CHR. Vander Linden, C. Bogaert, D. Colle, H. Colle (Ghent, Belgium)
Adaptor Protein Complex 4-associated Hereditary Spastic Paraplegia (AP-4-HSP): A Paradigm of Childhood-Onset Hereditary Spastic Paraplegia Caused By Defective Protein Trafficking

R. Behne, J. Teinert, M. Wimmer, S. Dwyer, A. Davies, J. Hirst, G. Borner, M. Robinson, L. Barrett, I. Chen, E. Buttermore, M. Sahin, D. Ebrahimi-Fakhari (Boston, MA, USA)
Addition of Opicapone to Safinamide in Parkinson’s Disease patients

M. Russo, C. Carrarini, F. Dono, M. Di Pietro, M. Rispoli, L. Ferri, M. Onofrj (Chieti, Italy)
ADL impairment and quality of life in patients with essential tremor

P. Reker, S. Schnitzler, T. Thies, A. Josten, J. Becker, J. Steffen, J. Wirths, H. Dafsari, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)
Adrenergic Receptor Modulation of Non-Motor Symptoms in Parkinson’s Disease

M. Rangwala, E. Hogg, E. Tan, H. Lu, A. Garland Becerra, M. Tagliati (Los Angeles, CA, USA)
Adult-onset neuronal intranuclear inclusion disease presenting with intractable resting and intention tremor

YY. Chang, MY. Lan, YF. Chen, JS. Liu (Kaohsiung, Taiwan)
Adult-Onset Parainfectious Opsoclonus-Myoclonus: Report of Two Cases

MI. Gaston, I. Rubio, J. Muruzabal, R. Larumbe, M. Martin, L. Martinez (Pamplona, Spain)
Adult-onset stereotypy — An atypical presentation of frontotemporal dementia

C. Walsh, L. Brennan, J. Ratliff (Philadelphia, PA, USA)
Advanced autonomous motor state detection from wrist-worn sensor in persons with PD

J. Goschenhofer, F. Pfister, K. Yuksel, J. Thomas, B. Fischl, A. Ceballos-Baumann, U. Fietzek (München, Germany)
Advanced Care Planning in complex Parkinson’s disease

L. Richardson, N. Butt, M. Khwaja, H. Avery, G. Alg, A. Chatterjee (Reading, United Kingdom)
Advanced Stage of Parkinson’s Disease: From Identification to Characterization and Disease Burden Assessment Using a Nationwide Database

Y. Barer, T. Gurevich, G. Chodick, N. Giladi, R. Gross, R. Cohen, L. Bergmann, Y. Jalundhwala, V. Shalev, A. Thaler (Tel Aviv-Yafo, Israel)
Aerobic exercise alters brain structure and function in Parkinson’s disease – a randomized controlled trial

M. Johansson, I. Cameron, N. Vander Kolk, N. de Vries, I. Toni, B. Bloem, R. Helmich (Nijmegen, Netherlands)
African American patients with Parkinson’s disease: A hospital-based study compared to Caucasian patients

T. Xie, D. Lee, M. Padmanaban, H. Yu, W. Kang, J. Johnson, J. Alshaikh, C. Yuen, M. Burns, F. Qian, B. Chiu (Chicago, IL, USA)
After-effects Of Transcranial direct current stimulation (tDCS) On Hand Biomechanics In A Patient With Secondary Dystonia

F. Yadolahi, M. Abedi (Tehran, Islamic Republic of Iran)
Age of onset and diagnosis of Essential Tremor

F. Jamal, S. Moore, G. Jackson, A. Sarwar (Houston, TX, USA)
Age-related failure in compensatory mechanisms and its relation to the Parkinson phenotype: evidence from a SPECT study in early and late-onset PD

G. Palermo, D. Frosini, S. Giannoni, M. Giuntini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)
Agreement Between the GAITRite® Walkway System and the Wearable Inertial Sensor BTS G-Walk® for Measurement of Gait Parameters

H. Horáková, K. Poláková, E. Růžička, H. Brožová (Prague, Czech Republic)
Alcohol- Induced Cerebellar Ataxia

B. Zeigelboim, H. Teive, C. Santos Junior, J. Malisky, M. da Rosa, R. Sampaio, M. José (Curitiba, Brazil)
Alexander Technique Group Classes Are a Feasible and Promising Intervention for Care Partners of People living with Parkinson’s disease

M. Gross, R. Ravichandra, B. Mello, R. Cohen (Candler, NC, USA)
Algorithm of a differentiated approach to the management of patients with tic hyperkinesis

S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)
Alignment of objective markers of speech with listener based judgements and disease severity in Friedreich ataxia

A. Vogel, A. Tsanas, H. Reece, L. Corben, G. Tai, M. Delatycki (Melbourne, Australia)
Alleviation of Parkinson’s and Associated Depression using Silymarin in Rotenone induced Mice Model of Parkinson’s Disease

D. Khatri (Pune, India)
Alpha-synuclein expression and cytokine profile in blood of patients with Lewy body dementias

T. Usenko, M. Nikolaev, A. Bezroukova, A. Emelyanov, E. Gracheva, I. Milukhina, Y. Belceva, N. Zalutskaya, A. Timofeeva, S. Pchelina (Gatchina, Russian Federation)
Alpha-synuclein interacts with BAF complex in nucleus

N. Sugeno, T. Hasegawa, J. Kobayashi, S. Yoshida, M. Ezura, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)
Alpha-synuclein promoter (SNCA-Rep1) polymorphism is associated with non-motor symptoms in early Parkinson’s disease

ASL. Ng, YJ. Tan, Y. Zhao, ZH. Lu, EYL. Ng, SYE. Ng, NSY. Chia, F. Setiawan, ZY. Xu, KY. Tay, WL. Au, EK. Tan, LCS. Tan (Singapore, Singapore)
Alpha-synuclein seeding activity in blood samples from synucleinopathy patients

T. Yamasaki, E. Song (Lexington, KY, USA)
Alterations of Blood Pressure Circadian Rhythm in Alpha-Synucleinopathies

A. Romagnolo, F. Vallelonga, A. Merola, C. Di Stefano, G. Sobrero, V. Milazzo, M. Zibetti, CA. Artusi, M. Fabbri, MG. Rizzone, S. Maule, L. Lopiano (Turin, Italy)
Altered intrinsic power spectral density of the precuneus in patients with hyperkinetic functional movement disorders

R. Marapin, H. Horn, J. Gelauff, B. de Jong, Y. Dreissen, J. Koelman, R. Renken, J. Marsman, M. Tijssen (Groningen, Netherlands)
Altered sensory processing in somatosensory and auditory domains in laryngeal dystonia

T. Mantel, C. Dresel, M. Welte, C. Zimmer, B. Haslinger (Munich, Germany)
Alternating bilateral deep brain stimulation in the internal pallidum and subthalamic nucleus in isolated segmental dystonia: a case report

A. Handberg, S. Jensen, AN. Høck, L. Hjermind, J. Brennum, B. Jespersen, M. Karlsborg, A. Løkkegaard (Copenhagen, Denmark)
Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson’s disease

A. Kopytova, M. Nikolaev, K. Senkevich, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)
Ambulatory monitoring of electrodermal activity (EDA) and Heart Rate Variability (HRV) for prediction of motor fluctuations in Parkinson’s Disease (PD)

D. Nene, P. Surathi, M. Mirian, W. Doo, M. Mckeown (Vancouver, BC, Canada)
Amimia in Parkinson’s Disease and its Relationship with Motor and Non-Motor Symptoms

T. Maycas-Cepeda, C. Feliz-Feliz, L. Gomez-Vicente, R. García-Cobos, P. Lopez-Ruiz, R. Arroyo, PJ. García- Ruiz (Pozuelo de Alarcon, Spain)
Amplification of α-synuclein aggregates in cerebrospinal fluid by rapid ultrasonication-based assay

K. Kakuda, K. Ikenaka, K. Araki, Y. Kajiyama, M. So, T. Ohmichi, Y. Nagai, T. Tokuda, Y. Goto, H. Mochizuki (Suita, Japan)
Amylin and insulin in Parkinson’s disease patients: a clinical and metabolic study

A. Sánchez-Gómez, M. Fernández, G. Alcarraz, R. Fernández, M. Ezquerra, A. Cámara, A. Novials, E. Muñoz, F. Valldeoriola, Y. Compta, MJ. Martí (Barcelona, Spain)
Amylin deposition in the brain of Parkinson’s disease patients

I. Martinez-Valbuena, R. Valenti-Azcarate, J. Sanchez, I. Marcilla Garcia, G. Marti Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)
Amylin single-nucleotide polymorphism and Parkinson’s disease

R. Valenti-Azcarate, I. Martinez-Valbuena, I. Marcilla Garcia, G. Marti, M. Carmona-Abellan, MT. Tuñon-Alvarez, MT. Luquin-Piudo (Pamplona, Spain)
Amyloid load and cognitive decline in Parkinson’s disease: preliminary longitudinal findings

M. Stark, T. Melzer, D. Myall, R. Keenan, T. Pitcher, KL. Horne, L. Livingston, M. Macaskill, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)
An adult type Niemann-Pick disease type C family: Huntington’s disease-like expression

I. Toyoshima, F. Takeda, C. Wada (Yurihonjo, Japan)
An atypical and interesting feature of Parkinson´s disease

B. Santos, M. Spitz (Rio de Janeiro, Brazil)
An examination of real-world onabotulinumtoxinA utilisation for the treatment of lower limb spasticity: The Adult Spasticity International Registry (ASPIRE) study

A. Esquenazi, W. Jost, G. Bavikatte, D. Bandari, M. Munin, A. Zuzek, A. Patel, J. Largent, G. Francisco (Elkins Park, PA, USA)
An examination of real-world onabotulinumtoxinA utilization for the treatment of upper limb spasticity: The Adult Spasticity International Registry (ASPIRE) study

G. Francisco, G. Bavikatte, W. Jost, D. Bandari, S. Tan Tang, A. Zuzek, A. Patel, J. Largent, A. Esquenazi (Taoyuan, Taiwan)
An Experimental Study to Assess the Professional and Social Consequences of Tardive Dyskinesia

R. Ayyagari, D. Goldschmidt, F. Mu, S. Caroff, B. Carroll (Boston, MA, USA)
An explorative study on the value of clinical features for diagnosing Parkinson’s disease

S. Suwijn, R. de Bie (Amsterdam, Netherlands)
An external relative to an internal focus of attention enhances motor learning in children with poor motor imagery ability

R. Abdollahipour, M. Bahmani, M. Babak, W. Land (Olomouc, Czech Republic)
An Informant-based Simple Questionnaire for Executive Function Assessment in Dementia with Lewy Bodies and Alzheimer’s Disease

YS. Liang, GU. Hung, CY. Wei, PY. Chiu (Changhua, Taiwan)
An Internet of Things system for patient empowerment: a case study on measuring patients’ understanding of causal relationships between symptoms and behaviour

L. Karni, M. Memedi, E. Kolkowska, I. Scandurra, P. de Roos, DA. Nyholm, G. Klein (Örebro, Sweden)
An open-label, 1-year extension clinical study in Japan of Opicapone treatment for Parkinson’s disease -Comfort-PD study part 2

A. Takeda, R. Takahashi, Y. Tsuboi, M. Nomoto, T. Maeda, A. Nishimura, N. Hattori (Sendai, Japan)
An outlook: Palliative care for patients with Parkinsonism syndrome

MI. Arain (Jamshoro, Pakistan)
An unusual cause of rhabdomyolysis in the patients with Parkinson’s disease: A report of two cases

J. Srikajon, P. Srivanitchapoom, Y. Pitakpatapee, T. Sangpeamsook, C. Satukijchai, A. Suengtaworn (Bangkok, Thailand)
An updated flow chart for the evaluation of chorea

R. Walker (Bronx, NY, USA)
Analysis from genotype to phenotype: Improvement in freezing of gait after subthalamic deep brain stimulation (STN-DBS) in a Parkinson’s disease patient with copy number variations of Parkin gene.

LW. Liu, WF. Yu, JL. Hu, S. Chen, ZX. Zhao, YM. Liu (Jinan, China)
Analysis of brain network changes due to focused ultrasound VIM thalamotomy

N. Tani, S. Oshino, K. Hosomi, H. Khoo, S. Yamamoto, T. Yanagisawa, N. Hattori, M. Kanemoto, H. Mochizuki, H. Kishima (Suita, Japan)
Analysis of brain-derived blood exosomes for diagnostics of synucleinopathies

S. Dutta, I. Rosario, K. Paul, J-A. Palma, S. Perlman, W. Poon, H. Kaufmann, B. Fogel, J. Bronstein, B. Ritz, G. Bitan (Los Angeles, CA, USA)
Analysis of cortical oscillatory activities may identify a subgroup of Parkinson’s disease patients with suboptimal responses to deep brain stimulation of the subthalamic nucleus

M. Bočková, M. Lamoš, P. Klimeš, P. Jurák, J. Halámek, S. Goldemundová, M. Baláž, I. Rektor (Brno, Czech Republic)
Analysis of Levodopa Content in Commercial Formulations of Mucuna pruriens Seeds Used in Integrative Treatment of Parkinson’s Disease

T. Denne (Kenmore, WA, USA)
Analysis of the role of known susceptibility genes of Parkinson’s disease in cancer

P-E. Sugier, M. Law, M. Iles, M. Meta-Analysis Consortium, M. Kvaskoff, T. Truong, A. Elbaz (Saint-Aubin, France)
Analysis of the Shape of the Gocovri Steady-state PK Profile: Implications for an Extended Release Product

R. Hauser, S. Isaacson, A. Mittur, A. Formella, R. Patni (Tampa, FL, USA)
Anatomical correlates of VTAs in directional STN DBS

M. Pilleri, M. Piacentino, S. Rinaldo, T. Mesiano, G. Ielo, M. Mondani, S. D'Auria, R. Eleopra (Milano, Italy)
Ancillary Service Utilization and Impact in Huntington’s Disease

J. Yomtoob, C. Yeh, D. Bega (Chicago, IL, USA)
Annual Incidence of Parkinson’s Disease in Mexico: A Report of National Public Health Institutions

E. Velazquez-Avila, D. Martinez-Ramirez, A. Banegas-Lagos, A. Cervantes-Arriaga, K. Salinas-Barbosa, S. Isais-Millan, M. Rodriguez-Violante (Monterrey, Mexico)
Another mitochondrial disease mimic: Two Case reports of adult riboflavin transporter deficiency (RTD) type 2 with muscle adenosine monophosphate (AMP) deaminase deficiency

L. Zhang, D. Thyagarajan (Melbourne, Australia)
Anterior EEG slowing in Dementia with Lewy Bodies: a multicenter European cohort study

L. Bonanni, R. Franciotti, F. Nobili, M. Kramberger, JP. Taylor, S. Garcia-Ptacek, M. Onofrj, NW. Falasca, D. Arnaldi, D. Aarsland (Chieti, Italy)
Anthropometric Profile and Vitamin D Status in the Functional Performance of a Brazilian Elderly Parkinsonian Population

L. Leandro, S. Kusma, H. Teive, C. Moreira (Curitiba, Brazil)
Antibiotic exposure and Risk for Parkinson’s Disease

T. Mertsalmi, E. Pekkonen, F. Scheperjans (Helsinki, Finland)
Antipsychotics Use in Parkinson’s Disease and Mortality Risks

WM. Liu, JH. Wang, HY. Chen, R. Lo (Hualien, Taiwan)
Anxiety and dopaminergic stimulation in patients with Parkinson´s disease.

A. Camacho Nieto, AR. Franco Salinas, L. Ruiz-Escribano Menchen, MJ. Gallardo Alcañiz, JP. Cabello Rosa, J. Vaamonde Gamo (Ciudad Real, Spain)
Apathy : Clinical Correlates in Parkinson’s disease Psychosis

YM. Wan, D. van Wamelen, V. Leta, D. Trivedi, A. Podlewska, TS. Lee, EK. Tan, D. Aarsland, K. Chaudhuri (London, United Kingdom)
Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia

B. Muñoz, J. Valderrama, L. Botero, J. Orozco (Cali, Colombia)
Apigenin loaded Phospholipid based nanoemulsion in Therapeutics of Parkinson’s Disease Via Attenuation of Oxidative Stress and Upregulation of Dopamine.

M-R. Rahman, V-K. Kumar (Allahabad, India)
Apomorphine induced hemolytic anemia: A case report and literature review

F. Hajiakhoundi, M. Motamed, M. Rohani, G. Shahidi (Tehran, Islamic Republic of Iran)
APOmorphine infusion and aMYLoid deposition in Parkinson’s disease (APOMYL): preliminary clinical and amyloid imaging data

D. van Wamelen, M. Politis, D. Aarsland, P. Odin, T. van Laar, T. Henriksen, B. Corcoran, G. Vivian, H. Wilson, M. Parry, A. Sauerbier, N. Mulholland, K. Chaudhuri (London, United Kingdom)
Appendectomy and risk of Parkinson’s disease: A meta-analysis using real-world evidence

S. Hussain, A. Najmi (New Delhi, India)
Applicability of modified definition of Vascular Parkinsonism in patients with Parkinsonism attending outpatient department: A tertiary care hospital-based study in south India

S. Jaiswal (Hyderabad, India)
Applicability of questionnaires and study of the prevalence of REM Sleep Behavior Disorder (RBD) in Parkinson’s disease

M. Cordellini, A. Machado, C. Costa (Curitiba, Brazil)
Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese

M. Olchik, C. Rieder, L. Scudeiro, R. Millette, R. Rech, A. Ayres (Porto Alegre, Brazil)
Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study

A. Antonini, J. Aldred, L. Bergmann, N. Kovács, P. Kukreja, W. Robieson, D. Standaert, KR. Chaudhuri (Padova, Italy)
Application of the Movement Disorders Society Criteria for diagnosis of Progressive Supranuclear Palsy

F. Ali, H. Botha, E. Ahlskog, J. Bower, A. Hassan, D. Dickson, J. Whitwell, K. Josephs (Rochester, MN, USA)
Approaches to assessing of disorders of voluntary posture control in patients with Parkinson’s disease

A. Buniak, I. Maryenko, S. Likhachev, O. Alenikova (Minsk, Belarus)
Appropriateness of DAT Scan Ordering in a University Hospital Practice

Z. Togher, S. Fullam, J. Britton, J. Duignan, R. Killeen, S. O'Riordan, M. Hutchinson (Dublin 4, Ireland)
Apraxia of Eye Lid Opening in patients with advanced Parkinson’s disease undergoing subthalamic stimulation – a single-centre experience.

K. Shetty, S. Krishan, K. Kesavapisharady, D. Puthenveedu, A. Kishore (Thiruvananthapuram, India)
Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?

L. Jacinto-Scudeiro, G. Machado, A. Ayres, D. Burguêz, M. Polese-Bonatto, C. González-Salazar, M. Siebert, M. França Jr, M. Olchik, J. Saute (Porto Alegre, Brazil)
Are there associations between altered brain connectivity and dopaminergic medication in Parkinson’s disease patients with freezing of gait?

A. Potvin-Desrochers, A. Atri, C. Paquette (Montreal, QC, Canada)
Are transventricular approaches associated with increased haemorrhage in functional stereotactic neurosurgery? A comparative study on 550 patients

J. Runge, A. Saryyeva, C. Blahak, C. Schrader, H. Bäzner, HH. Capelle, M. Abdallat, M. Wolf, TM. Kinfe, JK. Krauss (Hannover, Germany)
Are we underestimating the dysautonomic burden in GBA related a-synucleinopathies?

G. Lazzeri, E. Monfrini, I. Trezzi, M. Vizziello, M. Percetti, G. Franco, L. Borellini, A. Arighi, A. Di Fonzo (Milan, Italy)
Arm levitation as an early manifestation in MELAS syndrome: A case report

D. Gunal, I. Midi, E. Erdil (Istanbul, Turkey)
Art du Deplacement (ADD)/Parkour therapy for people with Parkinson’s disease (PDP)

M. Schwed, T. Getrost, K. Torchia, G. Yao (Pfungstadt, Germany)
Arterial spin labelling detects subcortical hypoperfusion in early drug-naïve patients with Parkinson’s disease

SP. Caminiti, G. Pagano, G. Dervenoulas, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)
Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): An Update on Recruitment

R. Schneider, L. Omberg, T. Myers, S. Anthwal, E. Kayson, C. Tarolli, M. Daeschler, E. Macklin, E. Dorsey, L. Mangravite, M. Schwarzschild, T. Simuni (Chicago, IL, USA)
Assessing the response to Levodopa/carbidopa intestinal gel infusion based on genetic status

A. Thaler, V. Livneh, A. Hillel, H. Strauss, G. Yahalom, H. Shabtai, A. Migirov Senderovich, S. Israeli-Korn, T. Fay-Carmon, N. Giladi, S. Hassin Baer, T. Gurevich (Ramat Gan, Israel)
Assessing the validity and reliability of MANAGE-PD tool to identify patients with Parkinson’s disease inadequately controlled on oral medications – Results from an international survey of general neurologists and movement disorder specialists

A. Antonini, P. Odin, Y. Jalundhwala, P. Schmidt, A. Skalicky, L. Kleinman, J. Zamudio, K. Onuk, P. Kukreja, Y. Bao, F. Cubillos, H. Fernandez (Padua, Italy)
Assessment of a Movement Disorders Video Curriculum for Neurology Clerkships

S. Bette, D. Shpiner, J. Margolesky, C. Luca, H. Moore, C. Singer, Y. Reyes-Iglesias (Miami, FL, USA)
Assessment of Caregiver Burden in Huntington’s disease

M. Yu, K. Tan, K. Koloms, D. Bega (Chicago, IL, USA)
Assessment of Gait in Huntington’s disease patients using EncephaLog smartphone’s application

NI. Inbar, N. Omer, A. Bar David, N. Geva, I. Dabakarov, L. Barsky, Z. Yekutieli, N. Giladi, T. Gurevich (Tel Aviv, Israel)
Assessment of neuronal morphology to determine the differential susceptibility to Parkinson’s disease using MPTP in two genetically distinct mice strains

B. Bhaduri, I. Datta, R. Yadav, P. Alladi (Bangalore, India)
Assessment of Neuropsychological Outcomes Using a New Multiple Source, Constant- Current Rechargeable Deep Brain Stimulation System for the Treatment of Parkinson’s Disease – INTREPID Study

A. Tröster, R. Jain, L. Chen, I. Study Group, M. Okun (Phoenix, AZ, USA)
Assessment of occupationally exposed organic solvents and welding fumes induced DNA damage and SNPs (PARK13, LRRK2 and CAST gene) and risk of Parkinson’s disease

K. Kalimuthu, R. Ramachndran, A. Arulsamy, S. Savariar (Annamalainagar, India)
Assessment of RADIAL, a tool for the diagnostic of autosomal recessive cerebellar ataxia: a prospective study

O. Gebus, M. Renaud, M. Koenig, J. Chelly, C. Tranchant, M. Anheim (Strasbourg, France)
Assessment of the risk of falls in patients with Parkinson’s disease using Time Up and Go

F. Sattolo, L. Rodrigues, L. Lima, M. Diogo, R. Guimarães (Campinas, Brazil)
Assessment, identification and classification of movement disorders in 22q11.2 deletion syndrome

W. Fung, A. Cunningham, T. Massey, J. Hall, M. Owen, M. Van-Den-Bree, K. Peall (Newport, United Kingdom)
Associated movements disorders to Hereditary Spastic Paraplegia (HSP) in a case series from South Spain

A. Adarmes Gómez, S. Jesús Maestre, D. Macías García, C. Méndez Del-Barrio, R. Martin, F. Carrillo García, P. Gómez Garré, P. Mir Rivera (Seville, Spain)
Association analysis between SCNN1A rs10849446, SPTLC3 rs6041636 and rs627354 and Parkinson’s disease and multiple system atrophy in a large Chinese population

XJ. Gu, YP. Chen, RW. Ou, B. Cao, HF. Shang (Chengdu, China)
Association between alteration in social cognition and impulse control disorder in Parkinson’s disease

L. Zuazua-Vidal, M. Rodríguez-Violante, R. Solís-Vivanco, A. Pérez-González, A. Alcocer-Salas, A. Cervantes-Arriaga (Mexico City, Mexico)
Association between coffee and chimarrão (yerba mate) ingestion and risk of Parkinson’s disease

MS. Medeiros, AF. Schumacher-Schuh, V. Altmann, CRM. Rieder (Porto Alegre, Brazil)
Association between Gait during Daily Life and Clinical Measures: Effects of Bout Length

V. Shah, J. Mcnames, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, F. Horak (Portland, OR, USA)
Association between hand functions, hand reaction time and balance in patients with idiopathic Parkinson’s disease

AC. Kalkan, T. Kahraman, BO. Ugut, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)
Association between Parkinson disease and the risk of cardiovascular disease and all-cause mortality: A nationwide, register-based cohort study

DH. Kim, DY. Kwon, MH. Park, KW. Park (Ansan City, Republic of Korea)
Association between quality of life and physical functions in patients with idiopathic Parkinson’s disease

BO. Ugut, T. Kahraman, AC. Kalkan, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)
Association between sleep disturbances in Parkinson’s disease and bioimaging

M. Nagai, T. Tsujii, R. Ando, Y. Yamanishi, S. Tada, Y. Hosokawa (Ehime, Japan)
Association between the side of onset and the motor and non-motor symptoms in Parkinson’s Disease

J. Silva, R. Guimarães, A. D'Abreu (Campinas, Brazil)
Association between transfer activities and health-related quality of life in patients with Parkinson’s disease

AC. Kalkan, T. Kahraman, BO. Ugut, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)
Association of active and passive smoking with Parkinson’s disease in women: the E3N cohort study

M. Canonico, F. Artaud, D. Cerasuolo, I. Degaey, P. Gerbouin-Rerolle, A. Kowal, E. Roze, G. Severi, MC. Boutron-Ruault, A. Elbaz (Villejuif, France)
Association of alexithymia and Parkinson’s Disease (PD) in Mexican population

L. Zuazua, M. Rodriguez, A. Cervantes, A. Balderas, R. Cruz, A. Alcocer, A. Perez, O. Esquivel, L. Navarro (Mexico City, Mexico)
Association of Charcot-Marie-Tooth disease, Parkinson’s disease and FIG4 mutations

I. Posada-Rodríguez, C. Domínguez-González (Madrid, Spain)
Association of genetic polymophisms with pharmacokinetics of levodopa in South indian PD patients

R. Borgohain, T. Sd, T. Syed, V. Kutala, R. Kandadai, S. Meka, S. Tandra (Hyderabad, India)
Association of metallic air pollution with Parkinson’s disease: a French nationwide incidence study

T. Vlaar, E. Lequy-Flahault, E. Moutengou, C. Meyer, S. Leblond, A. Elbaz, F. Moisan (Villejuif, France)
Association of MRI-derived estimated brain age and cognitive ability in Parkinson’s disease

K-L. Horne, R. Shoorangiz, L. Livingston, S. Grenfell, M. Almuqbel, B. Young, M. Pascoe, M. Livingstone, M. Macaskill, D. Myall, T. Pitcher, T. Anderson, J. Dalrymple-Alford, T. Melzer (Chrsitchurch, New Zealand)
Associations of gait disorders and future falls in the elderly: a prospective population-based study

K. Marini, P. Mahlknecht, O. Schorr, M. Baumgartner, A. Djamshidian, A. Gasperi, S. Kiechl, G. Rungger, H. Stockner, J. Willeit, W. Poewe, K. Seppi (Innsbruck, Austria)
Associations of Genetic, Epigenetic and Phenotypic Measures in the Dominican Republic PKAN Cohort

F. Middleton, A. Espinoza, D. Larocca, R. Ericson, M. Santana Jimenez, K. Wagner, P. Stoeter, C. Bass, C. Muniz, S. Baser (Pittsburgh, PA, USA)
Associations of microtubule associated protein tau (MAPT) H1 subhaplotypes and the MAPT H2 haplotype with demographic and clinical features in Parkinson`s disease

A. Deutschlander, M. Heckman, T. Konno, M. Ossi, N. Diehl, A. Soto, A. Strongosky, R. Uitti, J. van Gerpen, O. Ross, W. Zbigniew (Jacksonville, FL, USA)
Asymmetrical striatal dopamine transporter binding correlates with excess contralateral rest tremor

A. Fois, F. Chang, R. Barnett, K. London, N. Mahant, A. Ha, Z. Aldaajani, B. Cruse, H. Morales-Briceno, K. Ma, V. Fung (Dhahran, Saudi Arabia)
Asymmetry of motor symptoms in patients with Parkinson’s Disease

Y. Trufanov, N. Svyrydova, V. Svistun, I. Harkava, H. Bondarenko, N. Zhhilova (Kyiv, Ukraine)
Ataxia by Mutation in CACNA1A Gene – Case Series

P. Almeida, J. Pedroso, I. Brandi (Salvador, Brazil)
Ataxia with(out) oculomotor apraxia: A unique SETX mutation in 3 siblings

P. Khemani, A. Kuhlman, B. Bulica, N. Patel (Seattle, WA, USA)
Ataxin-2 gene in the Cuban population: Mutagenesis and epigenetic DNA methylation disease influencing phenotype

J. Laffita-Mesa, L. Velazquez Perez (Stockholm, Sweden)
ATP1A3 Gene Mutations Associated With Rapid-Onset Dystonia-Parkinsonism (RDP) Presenting As Functional Neurologic Disorder: A Report of Two Cases

T. Biller, R. Chuang, S. Ro (Seattle, WA, USA)
Atropine as Alternate Therapy for Treatment of Sialorrhea in Parksinson’s Disease

K. Papesh, J. Nguyen (Las Vegas, NV, USA)
Attentional Intervention to Improve Cognition and Gait in Parkinson’s Disease: Side of Onset Effects

A. Cronin-Golomb, O. Barthelemy, A. Marin, B. Davis, S. Alshuaib, T. Ellis, J. Degutis (Boston, MA, USA)
Attitude of Parkinson Patients towards Participation in Clinical Trials and Brain or Tissue Donation for Research

S. Khan, J. Foo, N. Chia, S. Agustin, S. Neo, T. Yaw, A. Lok, A. Ng, L. Tan (Singapore, Singapore)
Atypical presentation of Dopa-responsive dystonia- late onset with severe swallowing difficulty

C. Zhao, L. Li, H. Li, J. Zhang (Jinan, China)
Auditory processing in young patients of Essential Tremor

P. Shetty, Y. Belur, R. Yadav, P. Yuvaraj, A. Rajasekaran, N. Shivashankar, S. Hegde, P. Pal (Bangalore, Karnataka, India)
Auditory-Perceptual Voice and Speech Evaluation in ATP1A3-positive Patients

M. Finger, L. Madden, K. Ruckart, K. Downes, J. Cook, B. Snively, A. Brashear, I. Haq (Winston-Salem, NC, USA)
Augmented Brain Wave Synchronicity in Sleep in Parkinson’s Disease Patients

A. Hohler, O. Vaou, X. Zhang, J. Wang, A. Quaicoe, F. Lombardi, R. Endelapour, J. Holsapple, P. Ivanov (Boston, MA, USA)
Automated analysis for quantification of tremor from pen-on-paper Archimedes spirals

A. R, R. Rajan, A. Saini, A. Srivastava (New Delhi, India)
Automated analysis of neck muscle ultrasound can distinguish cervical dystonia from healthy controls

C. Kobylecki, R. Cunningham, A. Siddique, M. Sánchez, M. Edwards, M. Silverdale, I. Loram (Manchester, United Kingdom)
Automated Diagnosis of Idiopathic Parkinson’s Disease Using Deep Convolutional Neural Networks

YH. Sung, DH. Shin, EY. Kim (Incheon, Republic of Korea)
Automated Immunohistochemical Detection of Skin Depositions of Pathological alpha-Synuclein in Idiopathic REM Sleep Behavior Disorder and Parkinsonism

T-S. Tsao, A. Al-Qassabi, A. Racolta, KI. Taylor, W. Zago, RB. Postuma, S. Dziadek (Basel, Switzerland)
Automated Interpretation of FP-CIT-SPECT images based on Artificial Intelligence

M. Meier, J. Hammes, A. Drzezga, T. Dratsch, C. Kobe, D. Dos Santos, T. van Eimeren (Cologne, Germany)
Automated Metabolic Pattern Analysis in the Differential Diagnosis of Parkinsonism in a Swedish Cohort

I. Markaki, C. Tang, M. Lilja Lindström, D. Eidelberg, P. Svenningsson, I. Savitcheva (Stockholm, Sweden)
Automated Quantitative MRI Biomarkers in Differentiation of Progressive Supranuclear Palsy and Multiple System Atrophy from Parkinson Disease

H. You, Y. Luo, Y. Zhang, H. Wang, B. Hou, L. Shi, F. Feng (Beijing, China)
Automatic quantification of micro-sleep stability in isolated REM sleep behavior disorder and Parkinson’s disease

M-L. Muntean, M. Cesari, F. Sixel-Döring, B. Mollenhauer, JAE. Christensen, HBD. Sorensen, PJJ. Jennum, C. Trenkwalder (Kassel, Germany)
Autonomic dysfunction in early Parkinson’s disease: a prospective study

I. Stankovic, I. Petrovic, T. Pekmezovic, V. Markovic, T. Stojkovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)
Autonomic features in E46K-SNCA carriers

M. Carmona-Abellán, I. Gabilondo, A. Murueta, V. Khurana, R. Luquin, B. Tijero, R. Del Pino, M. Acera, R. Sanchez-Pernaute, JC. Gomez-Esteban (Bilbao, Spain)
Availability of levodopa and clinicopathological features of patients with multiple system atrophy

C. Ishida, K. Komai, K. Takahashi, Y. Motozaki, A. Tagami, S. Shibata, M. Asakawa (Kanazawa, Japan)
Availability of Parkinson’s disease medicines in Ghana: a national survey

M. Cham, I. Sefah, K. Oppon, R. Odikro, C. Amenorvi, A. Malik, J. Duah, G. Pezzoli, F. Baiden, R. Cilia (Sogakope, Ghana)
Awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease – Insights from an Indian Parkinson’s Registry

N. Sawal, K. Shukla (Chandigarh, India)